Location: San Francisco, CA
CIK: 0001056807 · Show all filings
Period: Q1 2020 (← Previous) (Next →)
Filing Date: May 15, 2020
Total Value: $1.073B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | PRINCIPIA BIOPHARMA INC | 1,583,595 | $94.03M | 8.8% | — | — | COM | 74257L108 |
| IONS | IONIS PHARMACEUTICALS INC | 1,944,517 | $91.94M | 8.6% | — | — | COM | 462222100 |
| ACIU | AC IMMUNE SA | 11,342,505 | $78.38M | 7.3% | — | — | SHS | H00263105 |
| — | SPRINGWORKS THERAPEUTICS INC | 2,767,630 | $74.73M | 7.0% | — | — | COM | 85205L107 |
| XOMA | XOMA CORP DEL | 2,773,385 | $56.44M | 5.3% | — | — | COM NEW | 98419J206 |
| XNCR | XENCOR INC | 1,689,300 | $50.48M | 4.7% | — | — | COM | 98401F105 |
| CYTK | CYTOKINETICS INC | 3,938,280 | $46.43M | 4.3% | — | — | COM NEW | 23282W605 |
| — | MERUS N V | 3,544,654 | $42.89M | 4.0% | — | — | COM | N5749R100 |
| — | CALITHERA BIOSCIENCES INC | 9,559,642 | $42.45M | 4.0% | — | — | COM | 13089P101 |
| — | MOLECULAR TEMPLATES INC | 2,850,271 | $37.88M | 3.5% | — | — | COM | 608550109 |
| RVMD | REVOLUTION MEDICINES INC | 1,398,070 | $30.63M | 2.9% | — | — | COM | 76155X100 |
| XENE | XENON PHARMACEUTICALS INC | 2,674,338 | $30.33M | 2.8% | — | — | COM | 98420N105 |
| CTMX | CYTOMX THERAPEUTICS INC | 3,921,973 | $30.08M | 2.8% | — | — | COM | 23284F105 |
| KURA | KURA ONCOLOGY INC | 2,434,696 | $24.23M | 2.3% | — | — | COM | 50127T109 |
| ANAB | ANAPTYSBIO INC | 1,690,237 | $23.88M | 2.2% | — | — | COM | 032724106 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 2,139,784 | $23.47M | 2.2% | — | — | COM | 87164F105 |
| REPL | REPLIMUNE GROUP INC | 1,975,209 | $19.69M | 1.8% | — | — | COM | 76029N106 |
| — | FIVE PRIME THERAPEUTICS INC | 7,783,001 | $17.67M | 1.6% | — | — | COM | 33830X104 |
| PHAT | PHATHOM PHARMACEUTICALS INC | 676,561 | $17.47M | 1.6% | — | — | COM | 71722W107 |
| — | GLYCOMIMETICS INC | 7,361,801 | $16.79M | 1.6% | — | — | COM | 38000Q102 |
| — | VERASTEM INC | 6,328,994 | $16.71M | 1.6% | — | — | COM | 92337C104 |
| IMVT | IMMUNOVANT INC | 999,996 | $15.56M | 1.5% | — | — | COM | 45258J102 |
| INFIQ | INFINITY PHARMACEUTICALS INC | 17,426,968 | $14.6M | 1.4% | — | — | COM | 45665G303 |
| — | MERSANA THERAPEUTICS INC | 2,372,400 | $13.83M | 1.3% | — | — | COM | 59045L106 |
| — | PIERIS PHARMACEUTICALS INC | 5,872,762 | $13.39M | 1.2% | — | — | COM | 720795103 |
| — | X4 PHARMACEUTICALS INC | 1,171,728 | $11.72M | 1.1% | — | — | COM | 98420X103 |
| — | ESSA PHARMA INC | 2,420,565 | $9.682M | 0.9% | — | — | COM NEW | 29668H708 |
| — | CIDARA THERAPEUTICS INC | 3,825,315 | $9.487M | 0.9% | — | — | COM | 171757107 |
| BDTX | BLACK DIAMOND THERAPEUTICS INC | 378,788 | $9.451M | 0.9% | — | — | COM | 09203E105 |
| — | SELECTA BIOSCIENCES INC | 3,609,472 | $8.699M | 0.8% | — | — | COM | 816212104 |
| — | MEI PHARMA INC | 5,046,272 | $8.124M | 0.8% | — | — | COM NEW | 55279B202 |
| — | KEZAR LIFE SCIENCES INC | 1,564,373 | $6.821M | 0.6% | — | — | COM | 49372L100 |
| — | CTI BIOPHARMA CORP | 6,929,690 | $6.375M | 0.6% | — | — | COM | 12648L601 |
| — | GALMED PHARMACEUTICALS LTD | 1,832,484 | $6.34M | 0.6% | — | — | SHS | M47238106 |
| — | AKERO THERAPEUTICS INC | 282,862 | $5.997M | 0.6% | — | — | COM | 00973Y108 |
| — | FORWARD PHARMA A/S | 925,724 | $5.378M | 0.5% | — | — | SPONSORD ADS NEW | 34986J204 |
| IDYA | IDEAYA BIOSCIENCES INC | 1,284,829 | $5.293M | 0.5% | — | — | COM | 45166A102 |
| — | PREVAIL THERAPEUTICS INC | 431,483 | $5.26M | 0.5% | — | — | COM | 74140Y101 |
| PTGX | PROTAGONIST THERAPEUTICS INC | 692,430 | $4.889M | 0.5% | — | — | COM | 74366E102 |
| — | SUTRO BIOPHARMA INC | 475,482 | $4.85M | 0.5% | — | — | COM | 869367102 |
| SPRO | SPERO THERAPEUTICS INC | 563,393 | $4.552M | 0.4% | — | — | COM | 84833T103 |
| CRVS | CORVUS PHARMACEUTICALS INC | 2,156,740 | $4.551M | 0.4% | — | — | COM | 221015100 |
| OVID | OVID THERAPEUTICS INC | 1,286,004 | $3.832M | 0.4% | — | — | COM | 690469101 |
| GNCAQ | GENOCEA BIOSCIENCES INC | 2,100,305 | $3.613M | 0.3% | — | — | COM NEW | 372427401 |
| — | ERYTECH PHARMA | 625,000 | $3.338M | 0.3% | — | — | SPONSORED ADR | 29604W108 |
| ARGX | ARGENX SE | 25,000 | $3.293M | 0.3% | — | — | SPONSORED ADR | 04016X101 |
| — | ALPINE IMMUNE SCIENCES INC | 1,137,764 | $3.277M | 0.3% | — | — | COM | 02083G100 |
| — | GAMIDA CELL LTD | 1,000,000 | $3.02M | 0.3% | — | — | SHS | M47364100 |
| — | SUNESIS PHARMACEUTICALS INC | 6,194,925 | $2.57M | 0.2% | — | — | COM | 867328700 |
| — | BIOLINERX LTD | 1,733,036 | $2.305M | 0.2% | — | — | SPONSORED ADS | 09071M205 |
| — | SURFACE ONCOLOGY INC | 983,051 | $1.838M | 0.2% | — | — | COM | 86877M209 |
| GLPG | GALAPAGOS NV | 7,674 | $1.503M | 0.1% | — | — | SPON ADR | 36315X101 |
| — | SPRING BK PHARMACEUTICALS INC | 951,701 | $885K | 0.1% | — | — | COM | 849431101 |
| — | REGULUS THERAPEUTICS INC | 1,592,923 | $734K | 0.1% | — | — | COM NEW | 75915K200 |
| RCUS | ARCUS BIOSCIENCES INC | 38,574 | $535K | 0.0% | — | — | COM | 03969F109 |
| — | EIGER BIOPHARMACEUTICALS INC | 68,054 | $463K | 0.0% | — | — | COM | 28249U105 |
| — | NOVUS THERAPEUTICS INC | 684,813 | $267K | 0.0% | — | — | COM | 67011N105 |